Tyrosine Kinase Inhibitors: all 10,744 studies that test it
Page 95 of 108. Open to participants first (1,949), then studies with results posted, then the rest; newest registration first within each.
- A Study to Explore Efficacy and Safety of ASP015K in Subjects With Moderate to Severe PsoriasisCompletedNCT01096862Phase 2
- Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid TumorsCompletedNCT01096030Phase 1
- Late Chronic Phase Chronic Myelogenous LeukemiaCompletedNCT01092741Phase 2
- Erlotinib Combined With Radiotherapy in Patients With Non-resectable Locally Advanced Non-small Cell Lung Cancer (LA-NSCLC)Status unknownNCT01091376Phase 2
- Sorafenib for Imatinib/Sunitinib-failed GISTCompletedNCT01091207Phase 2
- Safety, Pharmacokinetic (PK), Pharmcodynamic (PD), and Drug-Drug Interaction of PLX3397 in Patients With Rheumatoid Arthritis Who Are Receiving MethotrexateWithdrawnNCT01090570Phase 1
- Gemcitabine Hydrochloride, Cisplatin, and Sunitinib Malate as First-Line Therapy in Treating Patients With Locally Advanced And/or Metastatic Transitional Cell Carcinoma of the Urothelium (SUCCINCT)CompletedNCT01089088Phase 2
- Erlotinib in Higher Risk Myelodysplastic SyndromeCompletedNCT01085838Phase 1/2
- Standard Chemotherapy with or Without Nelarabine or Rituximab in Treating Patients with Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT01085617
- Imatinib Mesylate and Docetaxel in Non-Small Cell Lung Cancer (NSCLC)CompletedNCT01083589Phase 2
- Study Comparing Two Different Tablet Formulations Of Bosutinib Under Fed ConditionsCompletedNCT01080365Phase 1
- An Expanded Cohort Trial of Bortezomib and Sorafenib in Advanced Malignant MelanomaCompletedNCT01078961Phase 1
- Sorafenib and Vorinostat in Treating Patients With Advanced Liver CancerCompletedNCT01075113Phase 1
- Safety and Efficacy Study of KX2-391 for Treatment of Bone-Metastatic, Castration-Resistant Prostate CancerCompletedNCT01074138Phase 2
- Temsirolimus and Pazopanib in Patients With Advanced Solid TumorsCompletedNCT01072890Phase 1
- A Dose-escalation Study in Subjects With Advanced MalignanciesCompletedNCT01072266Phase 1
- A Safety Study to Evaluate Pazopanib Eye Drops in Healthy VolunteersCompletedNCT01072214Phase 1
- Phase Ib/II Study of Primary Chemotherapy With Paclitaxel, Gemcitabine, and SunitinibCompletedNCT01070706Phase 1/2
- A Study of ARQ 197 Versus Investigator's Choice of Second-Line Chemotherapy in Patients With Locally Advanced or Metastatic Gastric Cancer Who Have Progressive Neoplastic Disease Following Treatment With One Prior Chemotherapy RegimenWithdrawnNCT01070290Phase 2
- Study of Sunitinib in Subjects With High Risk Renal Cell CarcinomaWithdrawnNCT01070186Phase 2
- Neoadjuvant Sunitinib Treatment for Metastatic Clear Cell Renal Cell Carcinoma (RCC)Status unknownNCT01069770Phase 2
- A Study of ARQ 197 in Combination With ErlotinibCompletedNCT01069757Phase 1
- Dose Escalating Study With BAY43-9006 With Carboplatin, Paclitaxel and Bevacizumab in Untreated Stage IIIb Non-small Cell Lung Cancer (NSCLC)CompletedNCT01069328Phase 1
- Efficacy and Safety of BMS-690514 in Combination With Letrozole to Treat Metastatic Breast CancerCompletedNCT01068704Phase 2
- A Study of First or Second Line Treatment With Tarceva (Erlotinib) in Patients With Advanced Non-Small Cell Lung CancerCompletedNCT01066884Phase 4
- Glivec/Gleevec Pediatric (Age 1 to Less Than 4) PK Study in CML, Ph+ ALL Patients and Other Glivec/Gleevec® Indicated Hematological Disorders.TerminatedNCT01066468Phase 1
- Pemetrexed (ALIMTA) and Gefitinib (IRESSA®) in Never-Smoker and Adenocarcinoma Patients With Non-Small Cell Lung Cancer Previously Treated With Platinum-Based ChemotherapyStatus unknownNCT01066195Phase 3
- A Dose Escalating Clinical Trial of the IGF-1 Receptor Inhibitor AXL1717 in Patients With Advanced CancerCompletedNCT01062620Phase 1
- Dalteparin and Sunitinib Malate as First-Line Therapy in Treating Patients With Kidney Cancer That is Metastatic or Cannot Be Removed by SurgeryCompletedNCT01061411Phase 1
- Pazopanib + Vinorelbine in Non Small Cell Lung Cancer (NSCLC) and Breast CancerTerminatedNCT01060514Phase 1
- Phase II Pazopanib Study in Advanced DermatofibrosarcomasTerminatedNCT01059656Phase 2
- Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal TranslocationCompletedNCT01058434Phase 2
- Single Dose Study With 4SC-203 in Healthy VolunteersCompletedNCT01054937Phase 1
- A Single and Multiple Dose Study to Explore the Safety Of JNJ-40346527 In Healthy VolunteersCompletedNCT01054014Phase 1
- Curcumin for Type 2 Diabetic PatientsStatus unknownNCT01052597Phase 4
- A 12-week Study of 4 Doses of VX-509 in Subjects With Active Rheumatoid ArthritisCompletedNCT01052194Phase 2
- Curcumin Therapy in Patients With Impaired Glucose Tolerance and Insulin ResistanceStatus unknownNCT01052025Phase 4
- A Safety Study in Healthy Volunteers to Evaluate Safety, How Fast the Drug is Absorbed, and the Side Effects of the Drug in HumansCompletedNCT01051700Phase 1
- Dasatinib Combination for Chronic Lymphocytic Leukemia(CLL) With Refractory DiseaseStatus unknownNCT01051115Phase 2
- Reducing Symptom Burden - Non Small Cell Lung Cancer (NSCLC)WithdrawnNCT01048983Phase 1/2
- Gemcitabine and Oxaliplatin (Gem-Ox) Plus Glivec in Gemcitabine-refractory Pancreatic CancerCompletedNCT01048320Phase 1
- Efficacy and Safety Study of Sorafenib With Topotecan in Patients With Platinum-resistant Recurrent Ovarian CancerCompletedNCT01047891Phase 2
- A Double-blind, Placebo-controlled, Randomized, Parallel-group Study to Evaluate the Activity of Oral AB1010 in Adults Patients With Moderate to Severe Chronic Plaque PsoriasisCompletedNCT01045577Phase 2
- Lapatinib in Combination With Docetaxel in Patients With HER-2 Positive Advanced or Metastatic Breast CancerCompletedNCT01044485Phase 1/2
- Sorafenib Tosylate and Chemoembolization in Treating Patients With Unresectable Liver CancerCompletedNCT01042041Phase 1
- A Multi-Center, Non-Controlled Clinical Study of Sorafenib Adjuvant Therapy in Advanced Renal-Cell CarcinomaStatus unknownNCT01041482Phase 2
- A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung CancerCompletedNCT01039948Phase 1/2
- UFUR (Tegafur/Uracil) Plus Iressa in Non-small-cell Lung CancerCompletedNCT01037998Phase 2
- Trial on Safety and Pharmacokinetics of Intravaginal CurcuminCompletedNCT01035580Phase 1
- Sunitinib in Metastatic Renal CancerCompletedNCT01034878Phase 2
- Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to TreatmentCompletedNCT01031875Phase 2
- Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid TumorsCompletedNCT01030055Phase 1
- AZD6244 and Sorafenib in Advanced Hepatocellular CarcinomaTerminatedNCT01029418Phase 1/2
- A Study Evaluating Gemcitabine Plus Bosutinib for Patients With Resected Pancreatic CancerTerminatedNCT01025570Phase 1
- Ph+/Bcr-Abl+ ALL Imatinib and Nilotinib Rotational StudyCompletedNCT01025505Phase 2
- Paclitaxel, Carboplatin, and Gefitinib in Treating Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT01024712Phase 2
- Phase III Trial to Evaluate the Elortinib vs Gefitinib in Advanced NSCLC With EGFR Exon 19 or 21 MutationsCompletedNCT01024413Phase 3
- Sunitinib Malate Before and After Surgery in Treating Patients With Previously Untreated Metastatic Kidney CancerCompletedNCT01024205Phase 2
- A Study Of The Taste Of Different Oral Liquid Preparations Of CP-690,550 In Trained Adult Product TestersCompletedNCT01023100Phase 1
- Effect of Curcumin as Nutraceutical in Patients of DepressionCompletedNCT01022632Not applicable
- Sunitinib in Patients With Advanced Gastric Cancer and Treated With FOLFIRICompletedNCT01020630Phase 2
- A Bioequivalence Study Of AG-013736 Tablets Under Fed Conditions In Healthy VolunteersCompletedNCT01020136Phase 1
- Salvage Therapy With Sunitinib,Docetaxel and Platinum on Metastatic or Unresectable Non Small Cell Lung CancerStatus unknownNCT01019798Phase 2
- Multiple Ascending Dose Study of BMS-907351 (XL184) in Patients With Solid Tumors in JapanCompletedNCT01018745Phase 1
- Gefitinib 500mg Versus 250mg in Patients With NSCLC With Stable Disease After a Month Treatment of Gefitinib 250mgCompletedNCT01017679Phase 2
- OSI-906 and Irinotecan in Patients With Advanced CancerTerminatedNCT01016860Phase 1
- Dasatinib, Bevacizumab, Paclitaxel in Patients With Advanced MalignanciesCompletedNCT01015222Phase 1
- Erlotinib Hydrochloride in Preventing Cancer in Patients With Precancerous Lesions of the LungTerminatedNCT01013831Phase 1
- Phase 2, Endocrine Therapy + OSI-906 With or Without Erlotinib for Hormone-sensitive Metastatic Breast CancerWithdrawnNCT01013506Phase 2
- A Study of Imatinib and Valproic Acid in Patients With Chronic Myelogenous Leukemia (CML)WithdrawnNCT01011998Phase 2
- Sorafenib Tosylate and Chemoembolization With Doxorubicin Hydrochloride and Mitomycin in Treating Patients With Liver Cancer That Cannot Be Removed By SurgeryCompletedNCT01011010Phase 1
- Erlotinib, Gemcitabine and Nab-Paclitaxel in Advanced Pancreatic CancerCompletedNCT01010945Phase 1
- Efficacy and Tolerability of ABT-869 Versus Sorafenib in Advanced Hepatocellular Carcinoma (HCC)TerminatedNCT01009593Phase 3
- A Study Evaluating ABT-263 With Erlotinib, ABT-263 With Irinotecan, and ABT-263 Monotherapy in Cancer SubjectsCompletedNCT01009073Phase 1
- Temsirolimus and Sorafenib in Advanced Hepatocellular CarcinomaCompletedNCT01008917Phase 1
- Cixutumumab and Sorafenib Tosylate in Treating Patients With Advanced Liver CancerCompletedNCT01008566Phase 1
- Erlotinib for Treatment of PsoriasisWithdrawnNCT01006096Phase 2
- ELBA: Exemestane and Lapatinib in Advanced Breast CancerWithdrawnNCT01005641Phase 2
- Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant MelanomaCompletedNCT01005472Phase 1
- First-line Dasatinib Plus Conventional Chemotherapy in Adults With Newly Diagnosed Ph-Positive ALLCompletedNCT01004497Phase 2
- Trial of ZD6474 and Faslodex in Non-Small Cell Lung CancerWithdrawnNCT01004419Phase 1
- A Dose Escalation Study in Adult Patients With Advanced Solid MalignanciesCompletedNCT01004224Phase 1
- Autologous Transplantation for Chronic Myelogenous LeukemiaCompletedNCT01003054Phase 2
- Safety Study of BAY73-4506 in Patients With Hepatocellular CarcinomaCompletedNCT01003015Phase 2
- The Effect of Food (High Fat and Low Fat Breakfast) on the Pharmacokinetics of RegorafenibCompletedNCT01002378Phase 1
- Study Evaluating SKI-606 in Subject With Solid TumorsCompletedNCT01001936Phase 1
- Efficacy and Safety of Curcumin Formulation in Alzheimer's DiseaseTerminatedNCT01001637Not applicable
- Study to Assess Safety and Tolerability of AZD0530 in Combination With Carboplatin and PaclitaxelWithdrawnNCT01000896Phase 1
- Safety Study of Sorafenib Following Combined Therapy of Radiation and TACE for Liver CancerStatus unknownNCT00999843Phase 1/2
- Masitinib in Locally Advanced/Metastatic Gastro-intestinal Stromal Tumour (GIST)CompletedNCT00998751Phase 2
- Study of Temsirolimus, Erlotinib and Cisplatin in Solid TumorsCompletedNCT00998036Phase 1
- Trial of Sorafenib in Hepatocellular Cancer (HCC) Transplant PatientsCompletedNCT00997022Phase 1
- A Study in Cancer Patients to Evaluate the Bioequivalence of Alternative Formulations of LapatinibCompletedNCT00996762Phase 1
- Clinical Trial Evaluating the Combination of Vandetanib and Dasatinib During and After Radiation Therapy (RT) in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma (DIPG)CompletedNCT00996723Phase 1
- Phase I Study to Evaluate Safety, Pharmacokinetics and Pharmacodynamics of GSK2256098 in Healthy VolunteersCompletedNCT00996671Phase 1
- A Phase 1 Protocol of 5-Azacytidine and Erlotinib in Advanced Solid Tumor MalignanciesCompletedNCT00996515Phase 1
- WALTZ - Wet Age-Related Macular Degeneration (AMD) AL-39324 Treatment ExaminationCompletedNCT00992563Phase 2
- Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung CancerStatus unknownNCT00989690Phase 3
- Sorafenib With Irinotecan in Metastatic Colorectal Cancer (mCRC) and K-RAS MutationCompletedNCT00989469Phase 1/2
- Trial of ARQ 197 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Who Have Failed One Prior Systemic TherapyCompletedNCT00988741Phase 2